No products in the cart.
Roll over image to zoom in
BIOMYF 500MG TABLET
₹588.00₹691.74 (-15%)
Biomyf 500mg Tablet is an anti-inflammatory with an active ingredient known as Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop the rejection of organs for those who have had one of their organs (such as heart, kidney, or even liver transplantation). It is usually prescribed as a part of a treatment combination that includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. It is not recommended for pregnant women unless there are no other alternatives and the benefits outweigh any risks. Women who are born are advised to use the most effective contraception available when using this tablet to prevent the possibility of pregnancy. Live vaccines shouldn’t be administered when a person taking Biomyf 500mg Tablet because of the decreased vaccine effectiveness and risk of contracting infection. People taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood donation.
It is recommended not to use this medication if you have an allergy to it or other ingredients. Inform your physician about heart or liver disease before beginning treatment. Since this medication weakens the body’s immune defenses, it increases the risk of developing skin cancer. People should reduce their exposure to UV (UV) radiation. Consult your physician immediately when you experience bruises on your skin or body, fever, unresolved fatigue, dizziness, discoloration of the skin or eyes, vision impairment, diminished urinary output, or seizures following this medication. Biomyf 500 mg Tablet is an anti-inflammatory medication. It could affect the baby’s developing immune system and should not be used during breastfeeding. In certain situations, alternatives to drugs that have an improved safety profile while breastfeeding might be thought of as.